USD 1.31
(9.17%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 26.34 Million USD | 23.73% |
2022 | 21.29 Million USD | 138.4% |
2021 | -55.44 Million USD | -177.94% |
2020 | -19.94 Million USD | 68.48% |
2019 | -63.28 Million USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 6.35 Million USD | 2.67% |
2024 Q1 | 6.19 Million USD | -76.5% |
2023 FY | 26.34 Million USD | 23.73% |
2023 Q3 | 28.22 Million USD | 1.18% |
2023 Q2 | 27.89 Million USD | -0.22% |
2023 Q1 | 27.95 Million USD | 31.32% |
2023 Q4 | 26.34 Million USD | -6.68% |
2022 Q3 | -29.81 Million USD | -360.76% |
2022 Q2 | 11.43 Million USD | 130.9% |
2022 Q1 | -36.99 Million USD | 33.27% |
2022 FY | 21.29 Million USD | 138.4% |
2022 Q4 | 21.29 Million USD | 171.42% |
2021 Q4 | -55.44 Million USD | -457.1% |
2021 FY | -55.44 Million USD | -177.94% |
2021 Q3 | 15.52 Million USD | 153.1% |
2021 Q2 | 6.13 Million USD | -88.14% |
2021 Q1 | 51.72 Million USD | 359.3% |
2020 Q1 | 92.16 Million USD | 0.0% |
2020 FY | -19.94 Million USD | 68.48% |
2020 Q4 | -19.94 Million USD | 0.0% |
2019 FY | -63.28 Million USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Abbott Laboratories | 8.97 Billion USD | 99.707% |
Allurion Technologies Inc. | 3.82 Million USD | -589.581% |
Artivion, Inc. | 300.4 Million USD | 91.231% |
Avanos Medical, Inc. | 121.4 Million USD | 78.301% |
Butterfly Network, Inc. | -109.6 Million USD | 124.033% |
Butterfly Network, Inc. | -109.6 Million USD | 124.033% |
Bio-Rad Laboratories, Inc. | 1 Billion USD | 97.371% |
Boston Scientific Corporation | 8.62 Billion USD | 99.695% |
CONMED Corporation | 966.95 Million USD | 97.276% |
Edwards Lifesciences Corporation | -449.1 Million USD | 105.866% |
Paragon 28, Inc. | 36.39 Million USD | 27.614% |
Glaukos Corporation | 290.27 Million USD | 90.925% |
Globus Medical, Inc. | 53.11 Million USD | 50.403% |
Inspire Medical Systems, Inc. | -160.69 Million USD | 116.393% |
Integer Holdings Corporation | 1.01 Billion USD | 97.411% |
Medtronic plc | 24.76 Billion USD | 99.894% |
Myomo, Inc. | -6.27 Million USD | 520.127% |
Nevro Corp. | 117.61 Million USD | 77.602% |
Owlet, Inc. | -1.34 Million USD | 2064.356% |
Penumbra, Inc. | 66.85 Million USD | 60.599% |
Vicarious Surgical Inc. | -37.99 Million USD | 169.339% |
Smith & Nephew plc | 2.78 Billion USD | 99.053% |
STERIS plc | 3.17 Billion USD | 99.171% |
Stryker Corporation | 10.02 Billion USD | 99.737% |
Vapotherm, Inc. | 102.66 Million USD | 74.342% |
Zimmer Biomet Holdings, Inc. | 5.57 Billion USD | 99.528% |